Gliquidone Tablets

This product is a second-generation oral sulfonylurea hypoglycemic drug. It is a highly active pancreatic beta cell agent that binds to specific receptors on the pancreatic beta cell membrane and can induce the production of appropriate amounts of insulin to lower blood sugar concentration.

Main ingredient: Gliquidone. Molecular formula: C27H33N3O6S Molecular weight: 527.6

White flakes.

It is suitable for middle-aged and elderly non-insulin-dependent (i.e. type Ⅱ) diabetes that cannot be ideally controlled by diet therapy alone. It is especially suitable for type Ⅱ diabetes patients with poor renal function, diabetics over 60 years old, those who have repeated hypoglycemia while taking other oral diabetes drugs, and those who only need a small dose of oral drugs to control postprandial hyperglycemia. It can be used in combination with intermediate-acting or long-acting insulin. Those with secondary failure of oral diabetes drugs and those with poor efficacy of other sulfonyl drugs can still try to switch to this product.

Oral: Daily dose 15-120 mg, taken before meals. Usually, if the daily dose is less than 30 mg, take it once in the morning. Larger doses should be taken in the morning and evening. The maximum single dose should not exceed 60 mg, and the effect is better if taken 3 times a day. </p

This product is generally well tolerated, and very few people have skin allergic reactions, gastrointestinal reactions, mild hypoglycemia reactions and changes in the blood system.

It is contraindicated for patients with insulin dependence, pre-diabetic coma, diabetes combined with acidosis or ketosis, allergy to sulfonamides, and gestational diabetes.

Precautions for children: This experiment has not been conducted and there is no reliable reference. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: This experiment has not been conducted and there is no reliable reference.

1. The effect of this product can be enhanced when used in combination with salicylates, sulfonamides, phenylbutazone, anti-tuberculosis drugs, tetracyclines, monoamine oxidase inhibitors, b-receptor blockers, chloramphenicol, dicoumarols and cyclophosphamide. 2. Chlorpromazine, sympathomimetic drugs, corticosteroids, thyroid hormones, oral contraceptives and nicotinic acid preparations can reduce the hypoglycemic effect of this product. This product can reduce the patient's tolerance to alcohol, and alcohol may also enhance the hypoglycemic effect of the drug.

Keep away from light and store in sealed container.

30mg

60 months.

Tipr Pharmaceutical Co., Ltd.

• Founded in:

  1994-08-18

• Address:

  No. 29, Huixin Road, Binhai Science and Technology Park, Binhai Hi-tech Zone, Tianjin

• Tax NO.:

  91120116238991799D

• Registered Funds:

  50 million yuan

• Website:

  Log in to view

• Email:

  Log in to view